This document prepared and endorsed by the Working Party on Global Blood Safety of the International Society of Blood Transfusion presents elements, as of April 2020, to take into consideration in the preparation and transfusion of COVID-19 convalescent plasma as a possible treatment approach of COVID-19. The document covers the following important factors to have in mind when considering this treatment: (a) eligibility criteria of convalescent COVID-19 patients to donate whole blood or plasma, (b) pre-screening and pre-donation testing of convalescent COVID-19 donors; (c) criteria for collection of COVID-19 plasma; (d) post-donation treatment of plasma; and (e) it offers recommendations for plasma transfusion.

Original languageEnglish
Pages (from-to)485-487
Number of pages3
JournalVox Sanguinis
Issue number6
Publication statusPublished - Aug 1 2020


  • convalescent plasma
  • coronavirus
  • COVID-19
  • preparation
  • SARS-CoV-2
  • transfusion

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Points to consider in the preparation and transfusion of COVID-19 convalescent plasma'. Together they form a unique fingerprint.

Cite this